Daniel Levitt

2013

In 2013, Daniel Levitt earned a total compensation of $2.3M as Executive Vice President and Chief Medical Officer at CytRx.

Compensation breakdown

Bonus$300,000
Option Awards$1,483,000
Salary$525,000
Total$2,308,000

Levitt received $1.5M in option awards, accounting for 64% of the total pay in 2013.

Levitt also received $300K in bonus and $525K in salary.

Rankings

In 2013, Daniel Levitt's compensation ranked 3,404th out of 12,286 executives tracked by ExecPay. In other words, Levitt earned more than 72.3% of executives.

ClassificationRankingPercentile
All
3,404
out of 12,286
72nd
Division
Manufacturing
1,149
out of 4,612
75th
Major group
Chemicals And Allied Products
308
out of 1,462
79th
Industry group
Drugs
212
out of 1,156
82nd
Industry
Biological Products, Except Diagnostic Substances
30
out of 196
85th
Source: SEC filing on May 20, 2016.

Levitt's colleagues

We found four more compensation records of executives who worked with Daniel Levitt at CytRx in 2013.

2013

Steven Kriegsman

CytRx

Chief Executive Officer

2013

Benjamin Levin

CytRx

General Counsel

2013

John Caloz

CytRx

Chief Financial Officer

2013

Scott Wieland

CytRx

Senior Vice President – Drug Development

In-depth

You may also like